The largest database of trusted experimental protocols

Proox model p110

Manufactured by Biospherix
Sourced in United States, Switzerland

The ProOx Model P110 is a laboratory oxygen control system designed to precisely regulate oxygen levels within an enclosed environment. It features advanced sensors and a microprocessor-based control system to maintain the desired oxygen concentration.

Automatically generated - may contain errors

4 protocols using proox model p110

1

Hypoxic Stress and EV Treatment in HL-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HL-1 cells were cultured in Claycomb medium com-pleted with 10% fetal bovine serum (Euroclone, Milan, Italy), 2 mM L-glutamine, 0.1 mM norepirephrine, and 100 μg/mL penicillin/streptomycin (Lonza, Basel, Switzerland) under 0.2% hypoxia for 24 h using ProOx Model P110 (BioSpherix, 25 Union Street, Parish, NY 13131) hypoxia chamber as per the referred manual of ProOx Model P110. In CTRL sample, after 24 h of acute hypoxia stimulus, the cells were successively cultured in normoxia for the next 24 h at 37°C in a humidified atmosphere of 5% of CO2 in air. In the sample entitled HL-1 + EVs-hGMSCs UN, the HL-1 cells were maintained under acute hypoxic stimulus at 0.2% for 24 h and then treated with EVs derived from hGMSCs under normoxia for 24 h. In the sample entitled HL-1 + EVs-hGMSCs UH, the HL-1 were first treated with EVs derived from hGMSCs and kept in hypoxia at 0.2% for 24 h and then in normoxia for 24 h.
+ Open protocol
+ Expand
2

Hypoxia's Impact on Zebrafish Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
A hypoxia chamber (ProOx Model P110, BioSpherix, Parish, NY, USA) was used to create a hypoxic laboratory environment in which oxygen was reduced by nitrogen gas (HP, Airgas, Hyattsville, MD, USA). At 30 hpf larvae were exposed to hypoxia (1 mg/L oxygen) for 18 hr or to normoxia (outside of the chamber). Larvae were placed individually in wells of a 24-well plate (CytoOne, USA scientific, Ocala, FL, USA) containing 2 ml clean fish system-water. Twenty-four larvae were used per treatment for surface fish and 48 larvae for cavefish from two separate clutches of eggs per morph. To measure post-anal tail growth, each larva was imaged before placement in a well and again at the end of the treatment using a microscope as described above. Image-J was used to measure post-anal tail length (Figure 6A) and growth determined as the differential between the two time points. To measure eye size, eye diameter was measured after the 18 hr. hypoxia or normoxia treatment with ImageJ. After imaging, larvae were stained with o-dianisidine and blood cells were counted from images as described above.
+ Open protocol
+ Expand
3

Hypoxic Treatment of Lung MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cultured cells of both MSC-lung and MSCs-CPAM were seeded in a 6-multiwell plate with a density of 8 × 104 for each well. After seeding cells were maintained for 24 h in the standard medium MSCBM (Lonza) in incubator at 37°C with a humidified atmosphere at 5% CO2. Then cultured cells of MSC-lung and MSCs-CPAM were subjected to hypoxic treatment by inserting the plates into the ProOx Model P110 (BioSpherix, New York, NY, United States) hypoxia chamber for 24 h at 0.2% of hypoxia. Cells were observed under inverted light microscopy (Leica Microsystem, Milan, Italy) to evaluate the morphological features in normoxic and hypoxic conditions. Cultured cells of MSC-lung and MSCs-CPAM were maintained in incubator with normoxic condition and used as control cells.
+ Open protocol
+ Expand
4

Hypoxia Treatment of AtT20 and RPC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hypoxia treatment was performed using the Proox Model P110 and ProCO2 Model P120 hypoxia systems (BioSpherix, USA). AtT20 and RPC were moved to the hypoxia incubator in which the oxygen level was set as indicated (1% O2 hypoxia chamber with 1% O2, 5 % CO2, and 94% N2) or normoxia condition (21%O2) (Zhang et al., 2016; Zhao et al., 2013; Zhang et al., 2013) . AtT20 cells were treated with CRH(10 nM, Tocris Bioscience), PDTC (10 or 100 µM), antibody (NF-κB or AP-1) , or AP-1 inhibitor ( SR11302,1 or 10 µM, Tocris Bioscience ) for 24 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!